Trial
NCT01888965
Maintenance Dovitinib for Colorectal and Pancreas Cancer
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Georgetown University
Collaborators
Novartis
Condition
Colorectal Cancer
Intervention
Dovitinib
Why stopped
Adverse Event issues.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-07-19